Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2004Journal of Inherited Metabolic Disease

Enzyme replacement and enhancement therapies for lysosomal diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRobert J. DesnickUniversity of Siena

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Robert J. Desnick (2004) studied this question.

synapsesocial.com/papers/6a8cf3b1ea63fdd6cbf55526https://doi.org/10.1023/b:boli.0000031101.12838.c6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enzyme replacement in Tay‐Sachs disease1979 · 62 citations
  2. 2Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy2003 · 773 citations
  3. 3Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease2001 · 1,559 citations